References
-
1) miR-20b-5p exerts protective effects against experimental autoimmune encephalomyelitis in mice by inhibiting NLRP3 transcription and NLRP3/ASC/caspase-1 axis activation.
Year: 2023Journal: MOL CELL TOXICOLImpactFactor: 1.7DOI: 10.1007/s13273-023-00398-3 -
2) Oxalate‑induced renal pyroptotic injury and crystal formation mediated by NLRP3‑GSDMD signaling in vitro and in vivo.
-
3) Mir-25-3p in extracellular vesicles from fibroblast-like synoviocytes alleviates pyroptosis of chondrocytes in knee osteoarthritis.
Year: 2023Journal: J Bioenerg BiomembrImpactFactor: 3DOI: 10.1007/s10863-023-09964-9PMID: 37725203 -
4) METTL3-mediated m6 A modification of circPRKAR1B promotes Crohn's colitis by inducing pyroptosis via autophagy inhibition.
-
5) Inhibition of PINK1-Mediated Mitophagy Contributes to Postoperative Cognitive Dysfunction through Activation of Caspase-3/GSDME-Dependent Pyroptosis.
Year: 2023Journal: ACS Chem NeurosciImpactFactor: 5DOI: 10.1021/acschemneuro.2c00691PMID: 36946264 -
6) Pectic polysaccharides derived from Hainan Rauwolfia ameliorate NLR family pyrin domain-containing 3-mediated colonic epithelial cell pyroptosis in ulcerative colitis.
Year: 2023Journal: Physiol GenomicsImpactFactor: 4.6DOI: 10.1152/physiolgenomics.00081.2022PMID: 36440907 -
7) ADAM metallopeptidase domain 10 knockdown enables podocytes to resist high glucose stimulation by inhibiting pyroptosis via MAPK pathway.
-
8) Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Year: 2023Journal: PhytomedicineImpactFactor: 7.9DOI: 10.1016/j.phymed.2023.154922PMID: 37321078 -
9) Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis.
-
10) HYDROMORPHONE MITIGATES CARDIOPULMONARY BYPASS-INDUCED ACUTE LUNG INJURY BY REPRESSING PYROPTOSIS OF ALVEOLAR MACROPHAGES.
-
11) MicroRNA-140-5p represses chondrocyte pyroptosis and relieves cartilage injury in osteoarthritis by inhibiting cathepsin B/Nod-like receptor protein 3.
Year: 2021Journal: BIOENGINEEREDImpactFactor: 4.9DOI: 10.1080/21655979.2021.1985342PMID: 34565303 -
12) Myocardin Reverses Hypoxia-Inducible Factor-1α Mediated Phenotypic Modulation of Corpus Cavernosum Smooth Muscle Cells in Hypoxia Induced by.
Product: MYOCD Antibody (#AF0023)Year: 2023Journal: WORLD J MENS HEALTHImpactFactor: 4.8DOI: 10.5534/wjmh.210226PMID: 35274501 -
13) KLHL38 facilitates STS‐induced apoptosis in HL‐1 cells via myocardin degradation.
Product: MYOCD Antibody (#AF0023)Year: 2022Journal: IUBMB LIFEImpactFactor: 4.6DOI: 10.1002/iub.2602PMID: 35112472 -
14) MBNL1 regulates isoproterenol‐induced myocardial remodelling in vitro and in vivo.
Product: MYOCD Antibody (#AF0023)Year: 2021Journal: J CELL MOL MEDImpactFactor: 5.3DOI: 10.1111/jcmm.16177PMID: 33295096 -
15) LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis.
Product: MYOCD Antibody (#AF0023)Year: 2020Journal: J MOL CELL CARDIOLImpactFactor: 5DOI: 10.1016/j.yjmcc.2019.12.013PMID: 31982428